The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

“It's well known that sensitivity is a major driver of commercial success and value for point-of-care tests,” said Jim Kadushin, Genisphere's Chief Operating Officer. “Genisphere's new process for ...

High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent days and pharmacies warning of “huge problems” with kit deliveries.

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...

Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...